TY - JOUR
T1 - In-vitro and in-vivo imaging of coronary artery stents with Heartbeat OCT
AU - Cecchetti, Leonardo
AU - Wang, Tianshi
AU - Hoogendoorn, Ayla
AU - Witberg, Karen T.
AU - Ligthart, Jurgen M.R.
AU - Daemen, Joost
AU - van Beusekom, Heleen M.M.
AU - Pfeiffer, Tom
AU - Huber, Robert A.
AU - Wentzel, Jolanda J.
AU - van der Steen, Antonius F.W.
AU - van Soest, Gijs
N1 - Funding Information:
This study was funded by ZonMW (Grant No. IMDI 104003006).
Funding Information:
The authors Mr. L. Cecchetti, Dr. A. Hoogendoorn, Ms. K.T. Witberg, Mr. J.M.R. Ligthart, Dr. H.M.M. van Beusekom have nothing to disclose. Dr. T. Wang reports that Erasmus MC has a patent licensing agreement with Terumo Corporation, pertinent to the present study. Dr. Wang has the right to receive royalties as part of this agreement. Dr. J. Daemen reports grants and personal fees from Acist Medical, grants and personal fees from Boston Scientific, grants and personal fees from Pulsecath, grants from Biotronik, grants and personal fees from Medtronic, grants from Pie Medical, outside the submitted work. Dr. T. Pfeiffer has a patent ‘Method for maintaining the synchronism of a fourier domain mode locked (FDML) laser’ issued and is employed at Optores GmbH, which produces FDML lasers. Dr. R.A. Huber has a patent US7414779B2 with royalties paid. Dr. J.J. Wentzel reports grants from European Research Council, during the conduct of the study. Dr. A.F.W. van der Steen reports that Erasmus MC has a patent licensing agreement with Terumo Corporation, pertinent to the present study. Dr. van der Steen has the right to receive royalties as part of this agreement. Dr. G. van Soest reports grants from Terumo Corporation, during the conduct of the study, grants from Vivolight Inc., outside the submitted work, and Erasmus MC has a patent licensing agreement with Terumo Corporation, pertinent to the present study. Dr. van Soest has the right to receive royalties as part of this agreement.
Publisher Copyright:
© 2020, The Author(s).
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - To quantify the impact of cardiac motion on stent length measurements with Optical Coherence Tomography (OCT) and to demonstrate in vivo OCT imaging of implanted stents, without motion artefacts. The study consists of: clinical data evaluation, simulations and in vivo tests. A comparison between OCT-measured and nominal stent lengths in 101 clinically acquired pullbacks was carried out, followed by a simulation of the effect of cardiac motion on stent length measurements, experimentally and computationally. Both a commercial system and a custom OCT, capable of completing a pullback between two consecutive ventricular contractions, were employed. A 13 mm long stent was implanted in the left anterior descending branch of two atherosclerotic swine and imaged with both OCT systems. The analysis of the clinical OCT images yielded an average difference of 1.1 ± 1.6 mm, with a maximum difference of 7.8 mm and the simulations replicated the statistics observed in clinical data. Imaging with the custom OCT, yielded an RMS error of 0.14 mm at 60 BPM with the start of the acquisition synchronized to the cardiac cycle. In vivo imaging with conventional OCT yielded a deviation of 1.2 mm, relative to the length measured on ex-vivo micro-CT, while the length measured in the pullback acquired by the custom OCT differed by 0.20 mm. We demonstrated motion artefact-free OCT-imaging of implanted stents, using ECG triggering and a rapid pullback.
AB - To quantify the impact of cardiac motion on stent length measurements with Optical Coherence Tomography (OCT) and to demonstrate in vivo OCT imaging of implanted stents, without motion artefacts. The study consists of: clinical data evaluation, simulations and in vivo tests. A comparison between OCT-measured and nominal stent lengths in 101 clinically acquired pullbacks was carried out, followed by a simulation of the effect of cardiac motion on stent length measurements, experimentally and computationally. Both a commercial system and a custom OCT, capable of completing a pullback between two consecutive ventricular contractions, were employed. A 13 mm long stent was implanted in the left anterior descending branch of two atherosclerotic swine and imaged with both OCT systems. The analysis of the clinical OCT images yielded an average difference of 1.1 ± 1.6 mm, with a maximum difference of 7.8 mm and the simulations replicated the statistics observed in clinical data. Imaging with the custom OCT, yielded an RMS error of 0.14 mm at 60 BPM with the start of the acquisition synchronized to the cardiac cycle. In vivo imaging with conventional OCT yielded a deviation of 1.2 mm, relative to the length measured on ex-vivo micro-CT, while the length measured in the pullback acquired by the custom OCT differed by 0.20 mm. We demonstrated motion artefact-free OCT-imaging of implanted stents, using ECG triggering and a rapid pullback.
UR - http://www.scopus.com/inward/record.url?scp=85081036379&partnerID=8YFLogxK
U2 - 10.1007/s10554-020-01796-7
DO - 10.1007/s10554-020-01796-7
M3 - Journal articles
C2 - 32112229
AN - SCOPUS:85081036379
SN - 1569-5794
VL - 36
SP - 1021
EP - 1029
JO - International Journal of Cardiovascular Imaging
JF - International Journal of Cardiovascular Imaging
IS - 6
ER -